H.C. Wainwright Reiterates Buy Rating on Cabaletta Bio Inc. (CABA)

April 29, 2026 7:25 AM

H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating and $16.00 price target on Cabaletta Bio Inc. (NASDAQ: CABA).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found